Skip to main content
Erschienen in: Infection 1/2020

01.11.2019 | Brief Report

Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study

verfasst von: Mariam Younas, Julie Royer, Sharon B. Weissman, Katie S. Waites, Sangita Dash, Hana Rac, P. Brandon Bookstaver, Julie Ann Justo, Linda Bell, Anton Maki Jr., Majdi N. Al-Hasan

Erschienen in: Infection | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This cross-sectional population-based study aims to determine overall incidence rate of Clostridioides difficile infection (CDI) in the State of South Carolina and provide an estimated cost of hospitalization due to community-associated CDI (CA-CDI).

Methods

All CDI cases in South Carolina were identified through National Healthcare Safety Network (NHSN) and the South Carolina Infectious Disease and Outbreak Network (SCION) from January 1, 2015 to June 30, 2016, excluding infants < 1 year of age.

Results

During the 18-month study period, 10,254 CDI events were identified in South Carolina residents with an overall incidence rate of 139/100,000 person-years. Over one-half of CDI cases were CA-CDI (5192; 51%) with an incidence rate of 71/100,000 person-years. Among patients with CA-CDI, 2127 (41%) required hospitalization with a median length of stay of 5 days. The annual burden of CA-CDI in South Carolina was estimated to be 9282 hospital days and $16,217,295 in hospitalization costs.

Conclusion

The incidence rate of CA-CDI in South Carolina has surpassed both community-onset healthcare facility associated and hospital-onset CDI combined. The heavy burden of CA-CDI justifies dedication of public health resources to combat CDI in ambulatory settings, through antimicrobial stewardship initiatives.
Literatur
1.
Zurück zum Zitat Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369–70 (PubMed: 26061850).PubMed Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369–70 (PubMed: 26061850).PubMed
3.
Zurück zum Zitat Bertakis KD, Azari R, Helms LJ, et al. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147–52 (PubMed: 10718692).PubMed Bertakis KD, Azari R, Helms LJ, et al. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147–52 (PubMed: 10718692).PubMed
4.
Zurück zum Zitat Thaden JT, Fowler VG, Sexton DJ, et al. Increasing incidence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States. Infect Control Hosp Epidemiol. 2016;37(1):49–54 (Pub Med: 26458226).CrossRef Thaden JT, Fowler VG, Sexton DJ, et al. Increasing incidence of extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States. Infect Control Hosp Epidemiol. 2016;37(1):49–54 (Pub Med: 26458226).CrossRef
6.
Zurück zum Zitat Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55 (PubMed: 20307191).CrossRef Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55 (PubMed: 20307191).CrossRef
7.
Zurück zum Zitat Crobach MJ, Planche T, Eckert C, et al. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22(Suppl 4):S63–81 (PubMed: 27460910).CrossRef Crobach MJ, Planche T, Eckert C, et al. European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22(Suppl 4):S63–81 (PubMed: 27460910).CrossRef
8.
Zurück zum Zitat Eastwood K, Else P, Charlett A, et al. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47(10):3211–7 (PubMed: 19710274).CrossRef Eastwood K, Else P, Charlett A, et al. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol. 2009;47(10):3211–7 (PubMed: 19710274).CrossRef
9.
Zurück zum Zitat Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67–73 (PubMed: 23011147).CrossRef Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67–73 (PubMed: 23011147).CrossRef
10.
Zurück zum Zitat Tenover FC, Tickler IA, Persing DH. Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother. 2012;56(6):2929–32 (PubMed: 22411613).CrossRef Tenover FC, Tickler IA, Persing DH. Antimicrobial-resistant strains of Clostridium difficile from North America. Antimicrob Agents Chemother. 2012;56(6):2929–32 (PubMed: 22411613).CrossRef
Metadaten
Titel
Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study
verfasst von
Mariam Younas
Julie Royer
Sharon B. Weissman
Katie S. Waites
Sangita Dash
Hana Rac
P. Brandon Bookstaver
Julie Ann Justo
Linda Bell
Anton Maki Jr.
Majdi N. Al-Hasan
Publikationsdatum
01.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2020
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01368-5

Weitere Artikel der Ausgabe 1/2020

Infection 1/2020 Zur Ausgabe

Images in Infection

Severe malaria

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.